Its not just officially cold andfluseason, itsRSVseason.
This makes RSV the number-one cause of hospitalization in infants.
An injection of monoclonal antibodies callednirsevimabAstraZenecasBeyfortuswas also FDA-approved for preventing severe RSV in infants and young childrenin 2023.

Getty Images
However, this injection needs to be given every month during RSV season and is very expensive.